Eugia Pharma Specialities Limited Methotrexate Export Data — India (DGFT 2022–2026)

Name: Eugia Pharma Specialities Limited Methotrexate Export Records India — #2 Exporter, 58 Shipments, $2.9M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Methotrexate

India Pharmaceutical Trade Intelligence

$34.9M353 Suppliers148 CountriesHS 30049042

ExportsIndia → UNITED KINGDOM29.6%India → UNITED STATES16.3%

ImportsUNITED STATES → India$53.1K GERMANY → India$5.5K

#1 Supplier: CIPLA LIMITED #1 Buyer: ALLOGA UK

Eugia Pharma Specialities Limited — Methotrexate Exporter #2 | $2.9M Trade Value | TransData Nexus | TransData Nexus

Eugia Pharma Specialities Limited — Methotrexate Exporter Profile

Indian Pharmaceutical Exporter · #2 for Methotrexate · $2.9M export value · DGFT Verified

Eugia Pharma Specialities Limited is the #2 Indian exporter of Methotrexate with $2.9M in export value and 58 verified shipments. Eugia Pharma Specialities Limited holds a 8.3% market share in Methotrexate exports across 3 countries. The company exports 49 pharmaceutical products worth $170.1M across 14 therapeutic categories.

Eugia Pharma Specialities Limited — Methotrexate Export Profile: Buyers & Destinations

Eugia Pharma Specialities Limited Methotrexate export treemap — buyers and destination countries | TransData Nexus

Where Does Eugia Pharma Specialities Limited Export Methotrexate?

Country	Value	Shipments	Share
UNITED STATES	$1.7M	41	92.1%
UNITED STATES OF AMERICA	$100.0K	2	5.4%
CANADA	$47.0K	1	2.5%
MALTA	$12	14	0.0%

Who Are the Top Buyers of Methotrexate from Eugia Pharma Specialities Limited?

Buyer	Country	Value	Orders
AUROBINDO PHARMA USA., INC,	UNITED STATES	$651.3K	19
AUROLOGISTICS LLC, (AUROBINDO PHARM	UNITED STATES	$566.0K	12
AUROBINDO PHARMA USA INC	UNITED STATES	$300.0K	6
AUROLOGISTICS LLC AUROBINDO PHARM	UNITED STATES	$100.0K	2
AUROLOGISTICS LLC (AUROBINDO PHARM	UNITED STATES	$100.0K	2
AUROBINDO PHARMA USA. INC	UNITED STATES	$100.0K	2
AURO PHARMA INC,	CANADA	$47.0K	1
APL SWIFT SERVICES (MALTA) LIMITED	MALTA	$12	5
APL SWIFT SERVICES (MALTA) LTD	MALTA	$0	5
APL SWIFT SERVICES (MALTA) LTD.	MALTA	$0	4

Eugia Pharma Specialities Limited supplies Methotrexate to 10 buyers globally. The largest buyer is AUROBINDO PHARMA USA., INC, (UNITED STATES), followed by AUROLOGISTICS LLC, (AUROBINDO PHARM (UNITED STATES) and AUROBINDO PHARMA USA INC (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Methotrexate Formulations Does Eugia Pharma Specialities Limited Export?

Product Description / Formulation	Value	Shipments
METHOTREXATE TABLETS 2.5 MG (MANUFACTURE	$350.0K	7
METHOTREXATE TABLETS 2.5MG (METHOTREXATETABLETS 2.5 MG (100 S HDPE PACKING STAGE FOR USA)) (QTY: 35534 PACKS)NOS	$121.8K	3
METHOTREXATE TABLETS 2.5 MG (METHOTREXATE TABLETS 2.5 MG (100'S HDPE PACKING STAGE FOR USA)) (35543X100'S)	$116.0K	3
METHOTREXATE TABLETS 2.5 MG (METHOTREXAT	$100.0K	2
METHOTREXATE TABLETS 2.5MG(100 S HDPE PA	$99.0K	2
METHOTREXATE TABLETS 2.5 MG (METHOTREXATE TABLETS 2.5MG (100 S HDPE PACKING STAGE FOR USA)) (QTY: 17833 PACKS)	$60.3K	3
METHOTREXATE TABLETS 2.5 MG (METHOTREXATE TABLETS 2.5MG (100 S HDPE PACKING STAGE FOR USA)) (QTY: 17823 PACKS)	$60.3K	3
METHOTREXATE TABLETS 2.5 MG (METHOTREXATE TABLETS 2.5MG (100 S HDPE PACKING STAGE FOR USA)) (QTY: 17727 PACKS)	$59.9K	3
METHOTREXATE TABLETS 2.5 MG(100 S HDPE P	$50.0K	1
METHOTREXATE TABLETS 2.5 MG METHOTREXATE TABLETS 2.5 MG 100 S HDPE PACKING STAGE FOR USA QTY: 35613 PACKS	$50.0K	1

Eugia Pharma Specialities Limited exports 36 distinct Methotrexate formulations including tablets, capsules, syrups, and combination drugs. The top formulation is METHOTREXATE TABLETS 2.5 MG (MANUFACTURE with 7 shipments worth $350.0K.

How Does Eugia Pharma Specialities Limited Compare to Nearest Methotrexate Exporters?

Exporters ranked immediately above and below #2 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	CIPLA LIMITED	$10.8M	217	13	$50.0K
2	EUGIA PHARMA SPECIALITIES LIMITED ★	$2.9M	58	3	$50.0K
3	INTAS PHARMACEUTICALS LIMITED	$1.5M	109	11	$14.0K
6	NAPROD LIFE SCIENCES PRIVATE LIMITED	$1.2M	45	8	$25.6K

Eugia Pharma Specialities Limited ranks #2 among 353 Indian Methotrexate exporters. Average shipment value of $50.0K compared to the market average of $60.3K. The closest competitors by value are CIPLA LIMITED and INTAS PHARMACEUTICALS LIMITED.

Which Indian Ports Ship Methotrexate Exports?

Port	Shipments	% Share
SAHAR AIR	890	23.4%
SAHAR AIR CARGO ACC (INBOM4)	719	18.9%
DELHI AIR CARGO ACC (INDEL4)	415	10.9%
DELHI AIR	267	7.0%
Bombay Air	239	6.3%
NHAVA SHEVA SEA (INNSA1)	148	3.9%
HYDERABAD AIR	89	2.3%
Bombay Air Cargo	80	2.1%

Geopolitical & Trade Policy Impact on Eugia Pharma Specialities Limited's Methotrexate Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Eugia. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing increased freight costs and extended transit times. These logistical hurdles are particularly impactful for time-sensitive pharmaceutical shipments, necessitating strategic adjustments in supply chain management. (pharmaceuticalcommerce.com)

Conversely, U.S.-China trade tensions have opened avenues for Indian exporters. With the U.S. seeking to diversify its supply chains away from China, Indian pharmaceutical companies have the opportunity to capture a larger share of the U.S. market. Eugia's recent FDA approvals and product launches position it well to capitalize on this shift.

However, the imposition of new tariffs by the U.S. administration in August 2025, affecting over 60 countries including India, poses a significant challenge. These tariffs, reaching up to 39%, could impact nearly 55% of India's exports to the U.S., including pharmaceuticals. The increased cost burden may erode profit margins and affect competitiveness in the U.S. market. (apnews.com)

In the European Union, compliance with the Falsified Medicines Directive (FMD) remains a critical requirement. Indian exporters must ensure stringent adherence to serialization and traceability standards to maintain access to the EU market. Eugia's commitment to quality and regulatory compliance will be pivotal in navigating these regulatory landscapes.

Eugia Pharma Specialities Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the USFDA intensifying inspections and compliance requirements. Eugia's experience with the USFDA's warning letter for its Unit-III facility underscores the importance of robust quality management systems. Addressing these regulatory observations is crucial for maintaining market access and reputation.

Indian pharmaceutical companies, including Eugia, are investing in upgrading manufacturing practices to meet international standards. This proactive approach is essential to mitigate risks associated with non-compliance and to sustain growth in regulated markets.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Methotrexate shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Eugia Pharma Specialities Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 58 individual customs records matching Eugia Pharma Specialities Limited exporting Methotrexate, covering 36 formulations to 4 countries via 10 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 148+ countries, 879+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Methotrexate

Methotrexate

Eugia Pharma Specialities Limited — Methotrexate Exporter Profile

Eugia Pharma Specialities Limited — Methotrexate Export Profile: Buyers & Destinations

Where Does Eugia Pharma Specialities Limited Export Methotrexate?

Who Are the Top Buyers of Methotrexate from Eugia Pharma Specialities Limited?

What Is India's Total Methotrexate Export Value and How Much Does Eugia Pharma Specialities Limited Contribute?

What Is the Average Shipment Value for Eugia Pharma Specialities Limited's Methotrexate Exports?

How Does Eugia Pharma Specialities Limited Compare to Other Indian Methotrexate Exporters?

What Methotrexate Formulations Does Eugia Pharma Specialities Limited Export?

Regulatory Requirements: Exporting Methotrexate to Key Markets

United States — FDA

Canada — HC

How Does Eugia Pharma Specialities Limited Compare to Nearest Methotrexate Exporters?

Which Indian Ports Ship Methotrexate Exports?

Methotrexate — Export Intelligence Video

Geopolitical & Trade Policy Impact on Eugia Pharma Specialities Limited's Methotrexate Exports

Eugia Pharma Specialities Limited — Regulatory Compliance & Quality Standards

About Eugia Pharma Specialities Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Methotrexate Export Data from Eugia Pharma Specialities Limited

Methotrexate Stats

Company Overview

Top Products by Eugia Pharma Specialities Limited

Related Analysis

Need Detailed Export Data?

Data Source